Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients

Introduction and Objectives: Psychotropic medications extend the corrected QT (QTc) period in the ECG. Psychiatric patients exposed to ≥ 1 psychotropic medication (s) represent a group with a marked probability of drug-activated QTc-prolongation. Prolonged QTc interval in elderly patients (age >...

Full description

Bibliographic Details
Main Authors: Biswadeep Das, Saravana Kumar Ramasubbu, Barun Kumar, Vikram Singh Rawat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=12;spage=6023;epage=6040;aulast=Das
id doaj-0c0ba928a68d453783f0a9bba841fcd6
record_format Article
spelling doaj-0c0ba928a68d453783f0a9bba841fcd62021-01-08T04:11:16ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632020-01-019126023604010.4103/jfmpc.jfmpc_1060_20Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatientsBiswadeep DasSaravana Kumar RamasubbuBarun KumarVikram Singh RawatIntroduction and Objectives: Psychotropic medications extend the corrected QT (QTc) period in the ECG. Psychiatric patients exposed to ≥ 1 psychotropic medication (s) represent a group with a marked probability of drug-activated QTc-prolongation. Prolonged QTc interval in elderly patients (age > 60 years) is connected to a greater risk of all-cause and coronary heart disease deaths. We investigated the pattern of utilization of QTc-interval prolonging medications, QT-extending interactions between drugs, and prevalence of QTc-interval prolonging risk factors in elderly patients. Methods: This was a cross-sectional, prospective study at the Psychiatry OPD at All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India from October 1, 2017 to December 31, 2018 employing the pertinent prescriptions. Results: A total of 208 elderly patients (age 60 years or more) visiting the Psychiatry OPD during the aforementioned study period were investigated. 105 (50.5%) patients were males whereas 103 (49.5%) were females in our study. 147 out of 208 patients (70.7%) were using interacting agents with the capacity to produce TdP. 288 interacting torsadogenic medication pairs were unraveled. As per AzCERT/CredibleMeds Classification, 254 (48.8%), 181 (34.8%), and 62 (12%) interacting medications were identified with known, possible, and conditional risk of TdP, respectively. The common interacting medications belonged to antidepressant (144), proton pump inhibitor (91), antipsychotic (85), anti-nausea (46), antimicrobial (39), and H2 receptor antagonist (15) therapeutic categories. Conclusions: Many geriatric patients were administered drugs and drug combinations with heightened proclivity towards QT-interval prolongation. Therefore, we need to exigently embrace precautionary safety interventions, to be vigilant, and forestall QT-prolongation and TdP in clinical settings. Online evidence-based drug information resources can aid clinicians in choosing drugs for psychiatric patients.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=12;spage=6023;epage=6040;aulast=Dasdrug-induced qt prolongationelderly patientspsychiatry opdpsychotropic drugstorsade de pointes
collection DOAJ
language English
format Article
sources DOAJ
author Biswadeep Das
Saravana Kumar Ramasubbu
Barun Kumar
Vikram Singh Rawat
spellingShingle Biswadeep Das
Saravana Kumar Ramasubbu
Barun Kumar
Vikram Singh Rawat
Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
Journal of Family Medicine and Primary Care
drug-induced qt prolongation
elderly patients
psychiatry opd
psychotropic drugs
torsade de pointes
author_facet Biswadeep Das
Saravana Kumar Ramasubbu
Barun Kumar
Vikram Singh Rawat
author_sort Biswadeep Das
title Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
title_short Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
title_full Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
title_fullStr Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
title_full_unstemmed Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
title_sort top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to qt interval prolonging drug use in elderly psychiatry outpatients
publisher Wolters Kluwer Medknow Publications
series Journal of Family Medicine and Primary Care
issn 2249-4863
publishDate 2020-01-01
description Introduction and Objectives: Psychotropic medications extend the corrected QT (QTc) period in the ECG. Psychiatric patients exposed to ≥ 1 psychotropic medication (s) represent a group with a marked probability of drug-activated QTc-prolongation. Prolonged QTc interval in elderly patients (age > 60 years) is connected to a greater risk of all-cause and coronary heart disease deaths. We investigated the pattern of utilization of QTc-interval prolonging medications, QT-extending interactions between drugs, and prevalence of QTc-interval prolonging risk factors in elderly patients. Methods: This was a cross-sectional, prospective study at the Psychiatry OPD at All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India from October 1, 2017 to December 31, 2018 employing the pertinent prescriptions. Results: A total of 208 elderly patients (age 60 years or more) visiting the Psychiatry OPD during the aforementioned study period were investigated. 105 (50.5%) patients were males whereas 103 (49.5%) were females in our study. 147 out of 208 patients (70.7%) were using interacting agents with the capacity to produce TdP. 288 interacting torsadogenic medication pairs were unraveled. As per AzCERT/CredibleMeds Classification, 254 (48.8%), 181 (34.8%), and 62 (12%) interacting medications were identified with known, possible, and conditional risk of TdP, respectively. The common interacting medications belonged to antidepressant (144), proton pump inhibitor (91), antipsychotic (85), anti-nausea (46), antimicrobial (39), and H2 receptor antagonist (15) therapeutic categories. Conclusions: Many geriatric patients were administered drugs and drug combinations with heightened proclivity towards QT-interval prolongation. Therefore, we need to exigently embrace precautionary safety interventions, to be vigilant, and forestall QT-prolongation and TdP in clinical settings. Online evidence-based drug information resources can aid clinicians in choosing drugs for psychiatric patients.
topic drug-induced qt prolongation
elderly patients
psychiatry opd
psychotropic drugs
torsade de pointes
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=12;spage=6023;epage=6040;aulast=Das
work_keys_str_mv AT biswadeepdas top20drugdruginteractionspolypharmacyandanalysisofthenatureofriskfactorsduetoqtintervalprolongingdruguseinelderlypsychiatryoutpatients
AT saravanakumarramasubbu top20drugdruginteractionspolypharmacyandanalysisofthenatureofriskfactorsduetoqtintervalprolongingdruguseinelderlypsychiatryoutpatients
AT barunkumar top20drugdruginteractionspolypharmacyandanalysisofthenatureofriskfactorsduetoqtintervalprolongingdruguseinelderlypsychiatryoutpatients
AT vikramsinghrawat top20drugdruginteractionspolypharmacyandanalysisofthenatureofriskfactorsduetoqtintervalprolongingdruguseinelderlypsychiatryoutpatients
_version_ 1724345075745423360